Skip to main content

Table 4 Correlation between SMARCC1 and immune checkpoints expression

From: Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma

immune cells

None

Purity

tumor cells

None

Purity

Rho

P

Rho

P

Rho

P

Rho

P

PD1

0.23

< .001

0.23

< .001

PDL1

0.28

< .001

0.29

< .001

CTLA4

0.20

< .001

0.22

< .001

PDL2

0.10

0.051

0.11

0.031

CD28

0.30

< .001

0.31

< .001

CD80

0.20

< .001

0.20

< .001

LAG3

0.12

0.014

0.14

0.007

CD86

0.28

< .001

0.29

< .001

CD226

0.24

< .001

0.25

< .001

FGL1

− 0.23

< .001

− 0.21

< .001

TIGIT

0.21

< .001

0.24

< .001

LGALS3

0.19

 < .001

0.20

< .001

CD96

0.18

< .001

0.20

< .001

CD112

0.24

< .001

0.24

< .001

BTLA

0.18

< .001

0.19

< .001

CD115

0.20

< .001

0.22

< .001

VISTA

0.27

< .001

0.27

< .001

HVEM

0.16

0.001

0.16

0.002

TIM3

0.27

< .001

0.29

< .001

CEACAM1

0.11

0.025

0.13

0.009